Contact
searchSearch
HMP Global
Quiz

Risankizumab Mechanism of Action

Jessica Garlewicz, Digital Managing Editor
09/22/2023
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates. 

Popular Articles

Linda Stein Gold, MD
Conference Coverage
Continuing Education and Strong Communication: How to Improve the Dermatology Team
09/21/2023
Jessica Garlewicz
At the start of the second day of Fall Dermatology Week 2023, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, and Linda Stein Gold, MD, presented their session, “The Dermatology Team."
At the start of the second day of Fall Dermatology Week 2023, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, and Linda Stein Gold, MD, presented their session, “The Dermatology Team."
At the start of the second day...
09/21/2023
The Dermatologist
psoriasis
FDA Alerts
Bimekizumab-bkzx Approved for Adults With Moderate to Severe Plaque Psoriasis
10/19/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
The US Food and Drug...
10/19/2023
The Dermatologist
Dr Benjamin Ungar
Conference Coverage
Epidemiology and Risk Factors Associated With Alopecia Areata
12/01/2023
Jessica Garlewicz
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
Prior to his session, Dr...
12/01/2023
The Dermatologist
Atopic Derm
FDA Alerts
Dupixent Receives Expanded FDA Approval for Atopic Dermatitis with Moderate to Severe Hand and Foot Involvement
01/19/2024
Riya Gandhi, MA
The US FDA has approved an update to the label for Dupixent (dupilumab) for atopic dermatitis for patients ages 12 years and older with AD and uncontrolled moderate to severe involvement of the hands and/or feet.
The US FDA has approved an update to the label for Dupixent (dupilumab) for atopic dermatitis for patients ages 12 years and older with AD and uncontrolled moderate to severe involvement of the hands and/or feet.
The US FDA has approved an...
01/19/2024
The Dermatologist
Cover Story
Decoding the Molecular Blueprint of Therapeutics in Dermatology
03/05/2024
Christopher G. Bunick, MD, PhD
Elucidating structure-function relationships of proteins involved in skin diseases and therapeutic agents and their targets generates new molecular insights that advance patient care.
Elucidating structure-function relationships of proteins involved in skin diseases and therapeutic agents and their targets generates new molecular insights that advance patient care.
Elucidating structure-function...
03/05/2024
The Dermatologist

Subscribe

The Dermatologist Newsletter
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist
JAK Inhibitors - headache
Quiz
Alopecia Areata—JAK Inhibitors
08/14/2025
Jessica Garlewicz
What is the most likely reason JAK inhibitors are effective in AA?
What is the most likely reason JAK inhibitors are effective in AA?
What is the most likely reason...
08/14/2025
The Dermatologist
Quiz
Medical Minimization of AA: What Contributed Historically?
08/14/2025
Riya Gandhi, MA
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Test your knowledge of how alopecia areata has been historically underrecognized in medicine. Which sociocultural or diagnostic factors contributed to its clinical minimization?
Test your knowledge of how...
08/14/2025
The Dermatologist
Quiz
Why Is Alopecia So Emotionally Impactful? Evolution Holds Clues
07/29/2025
Riya Gandhi, MA
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
Discover the evolutionary theory behind the emotional weight of alopecia areata. Quiz yourself on the biologic and social cues tied to hair visibility and human connection.
Discover the evolutionary theory...
07/29/2025
The Dermatologist
Atopic dermatitis
Quiz
The Overlooked Allergen Missing from Most Patch Test Panels
07/25/2025
Riya Gandhi, MA
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the right allergens? Take the quiz to learn which emerging culprit in skincare often flies under the radar.
Think you’re testing for all the...
07/25/2025
The Dermatologist
Atopic dermatitis
Quiz
Tacrolimus Aggravating Symptoms? Know the Next Best Step
07/18/2025
Riya Gandhi, MA
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during topical calcineurin inhibitor therapy, what's your next move? Quiz yourself on clinical best practices in ACD evaluation.
When dermatitis worsens during...
07/18/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use